Published online before print September 6, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2007.070251v1 171/5/1407    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Liu, A. C. Articles by Gotlieb, A. I. Search for Related Content PubMed PubMed Citation Articles by Liu, A. C. Articles by Gotlieb, A. I.

Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.070251

Accepted for publication July 6, 2007.

Article

The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology

From the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario; and the Department of Pathology, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada

^@ To whom correspondence should be addressed. E-mail: avrum.gotlieb{at}utoronto.ca.

	Abstract

The study of the cellular and molecular pathogenesis of heart valve disease is an emerging area of research made possible by the availability of cultures of valve interstitial cells (VICs) and valve endothelial cells (VECs) and by the design and use of in vitro and in vivo experimental systems that model elements of valve biological and pathobiological activity. VICs are the most common cells in the valve and are distinct from other mesenchymal cell types in other organs. We present a conceptual approach to the investigation of VICs by focusing on VIC phenotype-function relationships. Our review suggests that there are five identifiable phenotypes of VICs that define the current understanding of their cellular and molecular functions. These include embryonic progenitor endothelial/mesenchymal cells, quiescent VICs (qVICs), activated VICs (aVICs), progenitor VICs (pVICs), and osteoblastic VICs (obVICs). Although these may exhibit plasticity and may convert from one form to another, compartmentalizing VIC function into distinct phenotypes is useful in bringing clarity to our understanding of VIC pathobiology. We present a conceptual model that is useful in the design and interpretation of studies on the function of an important phenotype in disease, the activated VIC. We hope this review will inspire members of the investigative pathology community to consider valve pathobiology as an exciting new frontier exploring pathogenesis and discovering new therapeutic targets in cardiovascular diseases.